Narukjaporn Thammajaruk
Bangkok, Thailand
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
No significant drug-drug interaction between oral TAF-based PrEP and feminizing hormone therapy among transgender women in Thailand: the iFACT-3 study.
Journal: Journal of the International AIDS Society
Published: June 20, 2024
Exploring potential drug-drug interactions between masculinizing hormone therapy and oral pre-exposure prophylaxis (F/TDF and F/TAF) among transgender men (iMACT study): a randomized, open-label pharmacokinetic study in Thailand.
Journal: Journal of the International AIDS Society
Published: June 14, 2024
Pooled Pharyngeal, Rectal, and Urine Specimens for the Point-of-Care Detection of Chlamydia trachomatis and Neisseria gonorrhoeae by Lay Providers in Key Population-Led Health Services in Thailand.
Journal: Pathogens (Basel, Switzerland)
Published: October 03, 2023
Pharmacogenetics-based population pharmacokinetic analysis for dose optimization of ritonavir-boosted atazanavir in Thai adult HIV-infected patients.
Journal: Expert review of clinical pharmacology
Published: November 03, 2021
Acceptability and satisfaction towards self-collection for chlamydia and gonorrhoea testing among transgender women in Tangerine Clinic, Thailand: shifting towards the new normal.
Journal: Journal of the International AIDS Society
Published: March 25, 2021
Drug-drug interactions between feminizing hormone therapy and pre-exposure prophylaxis among transgender women: the iFACT study.
Journal: Journal of the International AIDS Society
Published: December 22, 2018
Determinants of Viral Resuppression or Persistent Virologic Failure After Initial Failure With Second-Line Antiretroviral Treatment Among Asian Children and Adolescents With HIV.
Journal: Journal of the Pediatric Infectious Diseases Society
Published: December 06, 2018
Pharmacokinetics and 48-week safety and efficacy of generic ritonavir tablet-boosted atazanavir in HIV-1-infected Thai adults.
Journal: Antiviral therapy
Published: September 24, 2018
Peg-interferon and ribavirin treatment in HIV/HCV co-infected patients in Thailand: efficacy, safety and pharmacokinetics.
Journal: Tropical medicine & international health : TM & IH
Published: December 17, 2017
Pharmacogenetics-based population pharmacokinetic analysis of tenofovir in Thai HIV-infected patients.
Journal: Pharmacogenomics
Published: October 25, 2017
Pharmacokinetics of rilpivirine and 24-week outcomes after switching from efavirenz in virologically suppressed HIV-1-infected adolescents.
Journal: Antiviral therapy
Published: September 19, 2017
Last Updated: 09/26/2026